FDA finalizes inaugural guidance allowing certain device makers to submit quarterly malfunction reports

By Laura DiAngelo, MPH

Seven years after its inception, the FDA has finalized its first guidance on the Voluntary Malfunction Summary Report (VMSR) program for medical devices. While industry groups had asked for some additional flexibility and clarity in response to the draft version of the document, the agency largely finalized the document in alignment with that 2022 draft.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap